InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001477449-23-000070 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-11-03 2023-11-02 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH S - Sale+OE $17.05 -35.9K 44.9K -44% -$611.9K
D 2023-11-03 2023-11-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx — +80.8K 80.8K New —
D 2023-11-03 2023-11-01 TDOC Kornwasser Laizer Pres, ENTERPRISE GROWTH M - OptEx $0.00 -80.8K 161.6K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-02 S D 35,887 $17.05 44,907 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2023-11-01 M A 80,794 — 80,794 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2023-11-01 M D 80,794 $0.00 161,588 D — · — to — 80,794 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.